8 Jan by Vitaliy Dadalyan Is Aeglea BioTherapeutics, Inc.'s (NASDAQ:AGLE) CEO Salary Justified? Anthony Quinn became the CEO of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) in 2017. This analysis aims first to…
